Skip to main content
. 2011 Jan 24;13(1):201. doi: 10.1186/bcr2791

Figure 1.

Figure 1

Correlating molecular and clinical characteristics can address the multiple aspects of biological, clonal and patient heterogeneity in breast cancer metastasis and lead to gene profiles, commercial assays and clinical trials that ultimately result in clinical applications to improve prognostic accuracy and treatment outcome for individual patients.